Share this article
Share this article
ResearchAndMarkets.com s offering.
The global genetic counseling market was valued at $972.2 million in 2019 and is anticipated to grow over $4,079.3 million by 2030.
The pharmacogenomic genetic counseling segment is expected to witness a robust CAGR of 17.39% during the forecast period, 2020-2030.
GeneDX and InformedDNA are currently the largest shareholders in the global genetic counseling market. This market dominance is attributed to the company s presence within the market through its expansive service portfolio, led by dedicated genetic counselors workforce that provides services in prenatal/preconception, pediatric, indication risk assessment, and pharmacogenomic counseling and other genetic counseling services.